Literature DB >> 28004315

Bioflavonoid Fisetin Loaded α-Tocopherol-Poly(lactic acid)-Based Polymeric Micelles for Enhanced Anticancer Efficacy in Breast Cancers.

Lei Wang1, De-Zhong Zhang1, Yu-Xia Wang2.   

Abstract

PURPOSE: In this study, tocopherol based polymeric micelles were successfully prepared to enhance the anticancer effect of fisetin (FIS) in breast cancer cells.
METHODS: The drug-loaded carrier was characterized in terms of physicochemical and in vivo parameters.
RESULTS: Compared to FIS, FIS-TPN showed higher cellular uptake in MCF-7 breast cancer cells as revealed by CLSM and flow cytometry. The cytotoxicity assay results clearly showed that the free FIS and FIS-TPN exhibited a typical dose-dependent toxic effect in MCF-7 breast cancer cells. Especially, enhanced cytotoxic effect of FIS was observed when loaded in a nanocarrier. Free FIS induced a ~11% apoptosis whereas FIS-TPN induced a significantly greater apoptosis of ~20% by the end of 24 h. At 48 h, similar trend continued and free FIS showed ~30% of apoptosis whereas ~42% cell apoptosis was observed in FIS-TPN treated group. Notably, migration of cancer cell was significantly inhibited when treated with FIS-TPN formulations. The FIS-TPN significantly reduced to tumor burden and H&E staining showed the lowest tumor volume and higher cell apoptosis.
CONCLUSIONS: All the findings suggest that the fisetin-loaded TPGS-PLA polymeric micelles serve as a potential candidate and promising alternative for the effective treatment of breast cancers.

Entities:  

Keywords:  anticancer; breast cancer; fisetin; polymeric micelles

Mesh:

Substances:

Year:  2016        PMID: 28004315     DOI: 10.1007/s11095-016-2077-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway.

Authors:  Tsung-Ho Ying; Shun-Fa Yang; Su-Ju Tsai; Shu-Ching Hsieh; Yi-Chang Huang; Da-Tian Bau; Yi-Hsien Hsieh
Journal:  Arch Toxicol       Date:  2011-10-01       Impact factor: 5.153

Review 2.  Applications of polymeric nanocapsules in field of drug delivery systems.

Authors:  Xinyu Rong; Yinghua Xie; Xiaomei Hao; Tao Chen; Yingming Wang; Yuanyuan Liu
Journal:  Curr Drug Discov Technol       Date:  2011-09

3.  Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan.

Authors:  T Ramasamy; H B Ruttala; J Y Choi; T H Tran; J H Kim; S K Ku; H G Choi; C S Yong; J O Kim
Journal:  Chem Commun (Camb)       Date:  2015-04-04       Impact factor: 6.222

4.  Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells.

Authors:  Ki Young Jang; Soo-Jin Jeong; Sun-Hee Kim; Ji Hoon Jung; Ji-Hyun Kim; Wonil Koh; Chang-Yan Chen; Sung-Hoon Kim
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

5.  Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment.

Authors:  Duarte de Melo-Diogo; Vítor M Gaspar; Elisabete C Costa; André F Moreira; David Oppolzer; Eugénia Gallardo; Ilídio J Correia
Journal:  Eur J Pharm Biopharm       Date:  2014-10-13       Impact factor: 5.571

6.  Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.

Authors:  Deeba N Syed; Farrukh Afaq; Nityanand Maddodi; Jeremy J Johnson; Sami Sarfaraz; Adeel Ahmad; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  J Invest Dermatol       Date:  2011-02-24       Impact factor: 8.551

7.  Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy.

Authors:  Pei-Ming Yang; Ho-Hsing Tseng; Chih-Wen Peng; Wen-Shu Chen; Shu-Jun Chiu
Journal:  Int J Oncol       Date:  2011-09-15       Impact factor: 5.650

8.  Anti-inflammatory activity of fisetin in human mast cells (HMC-1).

Authors:  Hyo-Hyun Park; Soyoung Lee; Jae-Min Oh; Myeung-Su Lee; Kwon-Ha Yoon; Byoung Hyun Park; Jeong Woo Kim; Haheon Song; Sang-Hyun Kim
Journal:  Pharmacol Res       Date:  2006-10-10       Impact factor: 7.658

9.  Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo.

Authors:  Kunimitsu Kanai; Eiji Kikuchi; Shuji Mikami; Eriko Suzuki; Yasumitsu Uchida; Kiichiro Kodaira; Akira Miyajima; Takashi Ohigashi; Jun Nakashima; Mototsugu Oya
Journal:  Cancer Sci       Date:  2009-09-14       Impact factor: 6.716

10.  Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs.

Authors:  Thiruganesh Ramasamy; Ziyad S Haidar; Tuan Hiep Tran; Ju Yeon Choi; Jee-Heon Jeong; Beom Soo Shin; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Acta Biomater       Date:  2014-08-25       Impact factor: 8.947

View more
  3 in total

Review 1.  Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review.

Authors:  Robert Kubina; Kamil Krzykawski; Agata Kabała-Dzik; Robert D Wojtyczka; Ewa Chodurek; Arkadiusz Dziedzic
Journal:  Nutrients       Date:  2022-06-23       Impact factor: 6.706

2.  Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer.

Authors:  Orleans Martey; Mhairi Nimick; Sebastien Taurin; Vignesh Sundararajan; Khaled Greish; Rhonda J Rosengren
Journal:  Int J Nanomedicine       Date:  2017-10-04

3.  Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies.

Authors:  Xu Sun; Xueman Ma; Qiwei Li; Yong Yang; Xiaolong Xu; Jiaqi Sun; Mingwei Yu; Kexin Cao; Lin Yang; Guowang Yang; Ganlin Zhang; Xiaomin Wang
Journal:  Int J Mol Med       Date:  2018-05-02       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.